1. Home
  2. ACA vs PTGX Comparison

ACA vs PTGX Comparison

Compare ACA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcosa Inc.

ACA

Arcosa Inc.

HOLD

Current Price

$135.84

Market Cap

5.5B

Sector

Industrials

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$112.86

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACA
PTGX
Founded
2018
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.4B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
ACA
PTGX
Price
$135.84
$112.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$120.00
$108.23
AVG Volume (30 Days)
244.9K
531.5K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.17%
N/A
EPS Growth
121.99
N/A
EPS
0.77
0.05
Revenue
$2,883,400,000.00
N/A
Revenue This Year
$5.26
$874.25
Revenue Next Year
$6.49
N/A
P/E Ratio
$175.74
$2,231.60
Revenue Growth
12.20
N/A
52 Week Low
$81.91
$49.86
52 Week High
$137.76
$114.49

Technical Indicators

Market Signals
Indicator
ACA
PTGX
Relative Strength Index (RSI) 66.33 63.61
Support Level $99.46 $94.48
Resistance Level N/A N/A
Average True Range (ATR) 4.11 4.89
MACD 0.95 1.38
Stochastic Oscillator 88.44 92.52

Price Performance

Historical Comparison
ACA
PTGX

About ACA Arcosa Inc.

Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: